# A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors

> **NCT05470933** · PHASE1 · TERMINATED · sponsor: **Suzhou Junjing BioSciences Co., Ltd.** · enrollment: 7 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** WJ01075

## Key facts

- **NCT ID:** NCT05470933
- **Lead sponsor:** Suzhou Junjing BioSciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-23
- **Primary completion:** 2023-04-18
- **Final completion:** 2023-04-18
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Terminate the study and close the research center based on strategic changes in product development, unrelated to drug safety.
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470933, "A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05470933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*